000			01496 a2200421 4500
005			20250515195312.0
264		0	_c20100114
008			201001s 0 0 eng d
022			_a1471-2202
024	7		_a10.1186/1471-2202-10-142 _2doi
040			_aNLM _beng _cNLM
100	1		_aMattis, Virginia B
245	0	0	_aSubcutaneous administration of TC007 reduces disease severity in an animal model of SMA. _h[electronic resource]
260			_bBMC neuroscience _cNov 2009
300			_a142 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAminoglycosides _xtherapeutic use
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aBlotting, Western
650	0	4	_aBrain _xmetabolism
650	0	4	_aCell Count
650	0	4	_aDisease Models, Animal
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aMotor Skills _xdrug effects
650	0	4	_aMuscle, Skeletal _xmetabolism
650	0	4	_aMuscular Atrophy, Spinal _xdrug therapy
650	0	4	_aSeverity of Illness Index
650	0	4	_aSpinal Cord _xmetabolism
650	0	4	_aStaining and Labeling
650	0	4	_aSurvival of Motor Neuron 1 Protein _xgenetics
700	1		_aFosso, Marina Y
700	1		_aChang, Cheng-Wei
700	1		_aLorson, Christian L
773	0		_tBMC neuroscience _gvol. 10 _gp. 142
856	4	0	_uhttps://doi.org/10.1186/1471-2202-10-142 _zAvailable from publisher's website
999			_c19331635 _d19331635